News

MPNRF visits the FDA

The FDA reached out to 3 MPN patient advocate groups including the MPN Research Foundation, had discussions about the concerns of MPN patients, and asked them to send representatives to an FDA Mini Symposium:

September is Blood Cancer Awareness Month

MPNRF has a few ways for you to take action

What does the approval of Kymriah mean for MPN?

MPNRF asks immunotherapy expert Saar Gill about what we can expect

MPN Landmark Survey funded by Incyte Corporation has been released

2017 Winners of the MPN Challenge Grant announced

Five projects focused on MPN research

Digital Sherpa Workshops

Join Patient Empowerment Network and MPN Research Foundation for Digital Sherpa Series

Follow up on the CALR mutation discovery

Dr. Hasselbach describes CALR as an immunotherapy target in new Leukemia submission.

BREAKING NEWS

AOP Orphan and PharmEssentia announces its latest clinical results for Ropeginterferon alfa-2b in Polycythemia Vera

Congratulations to Dr. Mesa on his Exciting Move

Dr. Mesa move to UT Health Center

The MPN Challenge RFP is now open

Apply for a grant now